Immunobladder Intravesical 80mg (Immunobladder® / イムノブラダー膀注用80mg)

JPY ¥20,000

Japanese Antineoplastic Biological Preparation (Dried BCG for Intravesical Use (Japan Strain) 80mg). For intravesical instillation in superficial bladder cancer and bladder carcinoma in situ. 80mg x 1 vial. Mfd. by Japan BCG Laboratory Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥18,400
10 - 19 12% JPY ¥17,600
20 + 18% JPY ¥16,400
SKU: IMM-80-EXT Category:

Description

Product Overview / 商品概要

Immunobladder Intravesical 80mg (イムノブラダー膀注用80mg)
Generic: Dried BCG for Intravesical Use (Japan Strain) / 乾燥BCG膀胱内用(日本株)
Therapeutic Category: Other Biological Preparations / Antineoplastic Agents / その他の生物学的製剤・抗悪性腫瘍剤
Manufactured by: Japan BCG Laboratory Co., Ltd. / 日本ビーシージー製造株式会社

Composition & Specification / 組成・規格

Active Ingredient: Live Bacillus Calmette-Guerin (BCG) (as approximately 70% moisture content) 80mg / 生きたカルメット・ゲラン菌(含水量約70%として)80mg
Additives: Sodium L-glutamate hydrate 140mg / L-グルタミン酸ナトリウム水和物 140mg
Appearance: Lyophilized preparation. When reconstituted with the accompanying solvent, becomes a white to pale yellow turbid liquid. pH 5.5-7.0, osmotic pressure ratio 1.05-1.16
外観: 乾燥製剤である。添付の溶剤を加えるとき、白色ないし淡黄色の混濁した液となる。pH 5.5~7.0、浸透圧比 1.05~1.16

Indications / 効能効果

EN: Superficial bladder cancer; Bladder carcinoma in situ (CIS)
JA: ○表在性膀胱癌
○膀胱上皮内癌

Dosage and Administration / 用法用量

EN: (1) Preparation: Add 2mL of the accompanying solvent (Japanese Pharmacopoeia normal saline) to one vial (80mg) to make a 40mg/mL suspension. Add a further 39mL of Japanese Pharmacopoeia normal saline to prepare a uniform BCG diluted solution.
(2) Administration: Insert a urethral catheter into the bladder under aseptic conditions and drain residual urine. Instill the diluted solution containing 80mg BCG into the bladder as slowly as possible through the catheter, and retain in the bladder for 2 hours in principle. Repeat once weekly for 8 weeks. Dose, frequency, and interval may be adjusted as appropriate according to patient condition.
JA: (1)薬剤の調製
通常、本品1本(80mg)に添付の溶剤(日本薬局方生理食塩液)2mLを加え40mg/mLの懸濁液とする。これに日本薬局方生理食塩液39mLを更に加え均等なBCG希釈液を調製する。
(2)投与方法
尿道カテーテルを膀胱内に無菌条件下で挿入し、残尿を排出した後、通常80mgのBCGを含有している希釈液を同カテーテルより膀胱内にできるだけゆっくりと注入し、原則として2時間膀胱内に保持するようにつとめる。これを通常週1回8週間繰り返す。なお、用量及び回数は症状に応じ適宜増減し、また、投与間隔も必要に応じ延長できることとする。

Contraindications / 禁忌

EN: 2.1 Patients with immunosuppression due to AIDS, leukemia, malignant lymphoma, or congenital/acquired immunodeficiency
2.2 HIV carriers
2.3 Patients with manifest active tuberculosis
2.4 Patients with febrile illness, urinary tract infection, or gross hematuria
2.5 Pregnant women or women who may be pregnant
2.6 Patients with a history of systemic BCG hypersensitivity reaction
2.7 Patients receiving immunosuppressants or immunosuppressive doses of corticosteroids
2.8 Patients undergoing anticancer therapy (cytotoxic chemotherapy or radiation; excluding durvalumab)
JA: 2.1 AIDS、白血病、悪性リンパ腫等により免疫抑制状態にある患者及び先天性又は後天性免疫不全の患者
2.2 HIVキャリアの患者
2.3 活動性の結核症が明白である患者
2.4 熱性疾患、尿路感染症又は肉眼的血尿が存在している患者
2.5 妊婦又は妊娠している可能性のある女性
2.6 BCG全身性過敏症反応の既往がある患者
2.7 免疫抑制剤及び免疫抑制量の副腎皮質ステロイド剤を投与中の患者
2.8 抗癌療法(細胞傷害性薬剤療法、放射線照射。ただし、デュルバルマブ(遺伝子組換え)を除く)中の患者

Regulatory Information / 規制情報

Approval No.: 21400AMZ00619000
Sales Started: March 1997 / 1997年3月
Classification Code: 876391
Storage: Store below 10°C, avoid freezing / 凍結を避け10℃以下に保存
Shelf Life: 2 years from the date of quality inspection approval / 検査合格の日から2年

Packaging / 包装

Main Package (for sale): 80mg x 1 vial (with accompanying solvent: Japanese Pharmacopoeia normal saline 2mL x 1 ampoule) / 80mg 1バイアル(添付溶剤:日本薬局方生理食塩液 2mL 1アンプル)
Other Available Packages (by special order): 80mg x 1 vial (with accompanying solvent: Japanese Pharmacopoeia normal saline 2mL x 1 ampoule)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Immunobladder Intravesical 80mg (Immunobladder® / イムノブラダー膀注用80mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Immunobladder Intravesical 80mg (Immunobladder®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.